Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaomeng Cui

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|June 3, 2021
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu ArteritisXiufang Kong, Ming Xu, Xiaomeng Cui, et al.
Molecular Medicine Reports|October 26, 2017
Synergistic regulatory effects of microRNAs on brain glioma cellsYilei Zhao, Xiaomeng Cui, Wenliang Zhu, et al.
Stem Cell Research|March 28, 2024
Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome)Baiqiang Wang, Qian Ren, Xiaomeng Cui, et al.
Modern Rheumatology|March 30, 2019
High melatonin levels are related to spinal ossification in patients with ankylosing spondylitisYanshan Li, Xiaomeng Cui, Zunzhong Li, et al.
The FEBS Journal|May 21, 2022
The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatinRuhua Wang, Yunong Fu, Menglin Yao, et al.
International Journal of Cardiology|May 7, 2018
Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamideXiufang Kong, Xiaojie Zhang, Peng Lv, et al.
Arthritis Research & Therapy|June 7, 2020
Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in ChinaXiufang Kong, Lili Ma, Peng Lv, et al.
Frontiers in Public Health|May 6, 2026
Trends in long COVID among US adults, 2022-2024Xiaoli Jia, Jingjing Wang, Xiaomeng Cui, et al.
Stem Cell Research|November 3, 2024
Generation of heterozygous KCNA2 knockout induced pluripotent stem cell lineWei Shan, Xiaomeng Cui, Dayan Wang, et al.
Joint Bone Spine|April 23, 2021
Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese populationSifan Wu, Xiufang Kong, Xiaomeng Cui, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|June 3, 2021
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu ArteritisXiufang Kong, Ming Xu, Xiaomeng Cui, et al.
Molecular Medicine Reports|October 26, 2017
Synergistic regulatory effects of microRNAs on brain glioma cellsYilei Zhao, Xiaomeng Cui, Wenliang Zhu, et al.
Stem Cell Research|March 28, 2024
Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome)Baiqiang Wang, Qian Ren, Xiaomeng Cui, et al.
Modern Rheumatology|March 30, 2019
High melatonin levels are related to spinal ossification in patients with ankylosing spondylitisYanshan Li, Xiaomeng Cui, Zunzhong Li, et al.
The FEBS Journal|May 21, 2022
The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatinRuhua Wang, Yunong Fu, Menglin Yao, et al.
International Journal of Cardiology|May 7, 2018
Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamideXiufang Kong, Xiaojie Zhang, Peng Lv, et al.
Arthritis Research & Therapy|June 7, 2020
Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in ChinaXiufang Kong, Lili Ma, Peng Lv, et al.
Frontiers in Public Health|May 6, 2026
Trends in long COVID among US adults, 2022-2024Xiaoli Jia, Jingjing Wang, Xiaomeng Cui, et al.
Stem Cell Research|November 3, 2024
Generation of heterozygous KCNA2 knockout induced pluripotent stem cell lineWei Shan, Xiaomeng Cui, Dayan Wang, et al.
Joint Bone Spine|April 23, 2021
Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese populationSifan Wu, Xiufang Kong, Xiaomeng Cui, et al.
Pageof 5